Redpin Therapeutics is a privately-held, preclinical stage gene therapy company based in New York City.  We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy.

Pharmaceutical

Redpin Therapeutics

Elma S. Hawkins

Scott Jeffers

David Bleakman

The executive team at Redpin Therapeutics has a history of working in the pharmaceutical industry. The team has experience working as executives at companies such as Quiet Therapeutics, Lion Biotechnologies, and Viridian Pharmaceuticals. In addition, the team has experience as a COO and Vice Chairman at Antigenics.

CEO and Executive Team

About

Team members

Other teams at Redpin Therapeutics

Leadership Team

Founding Team